ALLMedicine™ Acute Myeloblastic Leukemia Center
Research & Reviews 26 results
Leukemia Research; Mirfakhraie R, Noorazar L et. al.
Nov 23rd, 2021 - Acute myeloblastic leukemia (AML) is one of the most common types of blood malignancies that results in an AML-associated high mortality rate each year. Several causes have been reported as prognostic factors for AML in children and adults, the mo...
Haematologica Russell NH, Hills RK et. al.
Oct 15th, 2021 - Reduced Intensity Conditioning (RIC) transplantation is increasingly offered to older patients with acute myeloblastic leukemia (AML). We have previously shown that a RIC allograft, particularly from a sibling donor is beneficial in intermediate r...
Expert Review of Hematology; Cerchione C, Peleteiro Raíndo A et. al.
Aug 24th, 2021 - Introduction: Acute myeloblastic leukemia (AML) is the most frequent type of acute leukemia in adults with an incidence of 4.2 cases per 100,000 inhabitants and poor 5-year survival. Patients with mutations in the FMS-like tyrosine kinase 3 (FLT3)...
Journal of Pediatric Hematology/oncology; Aylan Gelen S, Sarper N et. al.
Jun 1st, 2021 - Indications of leukapheresis (LPh) and the prophylactic use of rasburicase in tumor lysis syndrome (TLS) of patients with acute leukemia with hyperleukocytosis are not clear. In this retrospective single-center pediatric study, the outcomes of pat...
Medicine Matei E, Aschie M et. al.
May 21st, 2021 - At present, various researches presented how subtypes of hematological malignancies are related to stages of the immune response, because the activated immune system represents a promising form in cancer treatment. This study explores the relation...